5-Bromo-4-chloro-3-indolyl beta-D-ribofuranoside, >=98.0% (HPLC)

5-Bromo-4-chloro-3-indolyl beta-D-ribofuranoside, >=98.0% (HPLC)

Application

Evaluation of novel beta-ribosidase substrates for the differentiation of Gram-negative bacteria

Legal Information

Supplied by Glycosynth Limited, U.S. Patent No. 7,323,488, European Patent Nos. 1436411 and 1438424, for use only in internal research conducted by the purchaser. No rights under the aforementioned patents are conveyed which permit the resale, transfer, or use for purposes other than research. Rights under the aforementioned patents, for purposes other than internal research, may be obtained by contacting Glycosynth Limited.

Packaging

Bottomless glass bottle. Contents are inside inserted fused cone.

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level InChI key InChI Manufacturer Storage Temp. Form Assay Price Quantity
3577956 5-Bromo-4-chloro-3-indolyl beta-D-ribofuranoside, >=98.0% (HPLC) 100 RYLVNYDICPAOQR-HUXSOILUSA-N 1S/C13H13BrClNO5/c14-5-1-2-6-9(10(5)15)7(3-16-6)20-13-12(19)11(18)8(4-17)21-13/h1-3,8,11-13,16-19H,4H2/t8-,11-,12-,13-/m1/s1 SIGMA-ALDRICH
£383.04 (exc VAT) per 100MG
-
+
3577957 5-Bromo-4-chloro-3-indolyl beta-D-ribofuranoside, >=98.0% (HPLC) 100 RYLVNYDICPAOQR-HUXSOILUSA-N 1S/C13H13BrClNO5/c14-5-1-2-6-9(10(5)15)7(3-16-6)20-13-12(19)11(18)8(4-17)21-13/h1-3,8,11-13,16-19H,4H2/t8-,11-,12-,13-/m1/s1 SIGMA-ALDRICH
£124.94 (exc VAT) per 25MG
-
+